首页> 外国专利> COMPOUND HAVING ACTIVITY SUPPRESSING ACTIVATION OF TGF-β RECEPTOR, METHOD OF SCREENING THE SAME, AND COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASE CAUSED BY HEPATITIS C

COMPOUND HAVING ACTIVITY SUPPRESSING ACTIVATION OF TGF-β RECEPTOR, METHOD OF SCREENING THE SAME, AND COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASE CAUSED BY HEPATITIS C

机译:具有抑制TGF-β受体活性的化合物,其筛查方法以及预防或治疗丙型肝炎引起的疾病的成分

摘要

An object is to provide a compound capable of inhibiting activation of TGF- receptors due to HCV, and a screening method for the compound. It has been found that a HCV-derived NS3 protease binds to type I TGF- receptor, and this binding results in activation of TGF- receptors. Moreover, binding sites between the NS3 protease and type I TGF- receptor were identified, and it has been found that antibodies recognizing these binding sites inhibit activation of TGF- receptors due to NS3 protease. Furthermore, it has been also found that screening for a compound capable of inhibiting activation of TGF- receptors can be performed by using the inhibition of the binding between NS3 protease and type I TGF- receptor or the like as an index.
机译:一个目的是提供一种能够抑制由于HCV引起的TGF-受体活化的化合物,以及该化合物的筛选方法。已经发现,源自HCV的NS3蛋白酶与I型TGF-受体结合,并且该结合导致TGF-受体的活化。此外,鉴定了NS3蛋白酶和I型TGF-受体之间的结合位点,并且已经发现识别这些结合位点的抗体由于NS3蛋白酶而抑制了TGF-受体的活化。此外,还发现可以通过抑制NS3蛋白酶与I型TGF-受体等之间的结合来筛选能够抑制TGF-β受体活化的化合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号